Australia markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2950-0.0060 (-1.99%)
At close: 04:00PM EDT
0.2996 +0.00 (+1.56%)
After hours: 07:44PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Assets
Current assets
Cash
Cash and cash equivalents
8,913
6,177
7,363
5,806
-
Other short-term investments
-
44.804
46.462
42.384
3,934
Total cash
8,913
6,177
7,410
5,848
-
Net receivables
260.399
88.027
11.919
45.344
-
Inventory
1,616
2,491
0
-
-
Other current assets
498.033
797.225
-
-
-
Total current assets
11,332
9,598
8,378
6,312
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,649
1,421
549.195
520.418
-
Accumulated depreciation
-925.321
-516.47
-222.6
-116.933
-
Net property, plant and equipment
723.426
904.252
326.595
403.485
-
Intangible assets
1,946
2,109
1,062
1,087
-
Other long-term assets
104.908
176.637
14.655
-
-
Total non-current assets
2,775
3,190
1,403
1,490
-
Total assets
14,106
12,788
9,781
7,803
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
544.179
1,166
775.129
706.516
-
Accrued liabilities
522.251
1,110
479.542
364.556
-
Total current liabilities
2,001
3,320
2,215
1,676
-
Non-current liabilities
Total non-current liabilities
15.994
389.498
189.288
248.011
-
Total liabilities
2,017
3,709
2,405
1,924
-
Stockholders' equity
Common stock
77,620
70,718
60,587
53,065
-
Retained earnings
-101,400
-93,453
-74,852
-64,649
-
Accumulated other comprehensive income
128.569
128.569
128.569
-301.874
-
Total stockholders' equity
12,090
9,079
7,377
5,878
-
Total liabilities and stockholders' equity
14,106
12,788
9,781
7,803
-